Captive Radiology Secures Growth Equity Investment From RC Capital

Why It Matters

The infusion of private‑equity capital accelerates Captive Radiology’s ability to meet rising demand for advanced diagnostic imaging, positioning it as a strategic partner for hospitals seeking rapid deployment of theranostic technologies.

Key Takeaways

• RC Capital invests in Captive Radiology to fuel national expansion
• Company operates 30 imaging partnerships in 20 states
• New PET‑CT services target prostate cancer detection
• Funding will boost service capabilities and rapid deployment
• CEO Kelly remains owner while scaling operations

Pulse Analysis

The radiology sector has become a hotbed for private‑equity activity as demand for high‑resolution diagnostics and theranostic therapies surges. Investors such as RC Capital, which has raised more than $1 billion across three decades, are targeting companies that can deliver turnkey imaging solutions at scale. By providing both equipment and operational expertise, these firms help hospitals bypass lengthy capital‑expenditure cycles and accelerate patient access to advanced scans. The latest infusion into Captive Radiology underscores a broader trend of capital flowing into providers that combine technology with managed services.

Captive Radiology, founded in 2003 and headquartered in North Canton, Ohio, already runs 30 imaging partnerships across 20 states, offering everything from project management to staffing and quality assurance. Its recent expansion into PET‑CT for prostate cancer reflects the growing importance of theranostics—imaging that directly informs targeted treatments. Partnerships with groups such as Urology of Indiana and OrthoUnited demonstrate a flexible, mobile‑scanner model that reduces upfront costs for providers while expanding service lines. The RC Capital investment will fund additional mobile units and enhance the company’s data‑analytics platform.

For health systems, the capital boost translates into faster rollout of cutting‑edge scans, potentially shortening diagnostic pathways and improving outcomes. Patients benefit from greater geographic access to PET‑CT and MRI, especially in underserved markets where standalone imaging centers are scarce. As insurers increasingly reimburse for theranostic procedures, providers that can offer integrated, cost‑effective solutions are poised for rapid growth. Captive Radiology’s scaling strategy, backed by seasoned healthcare investors, positions it to become a national conduit for next‑generation imaging, reshaping how hospitals meet evolving clinical demand.

Deal Summary

Imaging solutions provider Captive Radiology announced that private equity firm RC Capital has invested in the company to fund its nationwide expansion. The growth equity deal, disclosed on May 27, 2026, did not disclose the investment amount. Captive Radiology will use the capital to accelerate expansion and enhance its diagnostic imaging services.